Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A National, Multicentric, Observational, Prospective Study to Assess Immune Response to COVID-19 Vaccine in Frail Patients (VAX4FRAIL).

NCT04848493 is registered in ClinicalTrials.gov with Azienda USL Reggio Emilia - IRCCS as lead sponsor.

NCT NCT04848493
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04848493 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A National, Multicentric, Observational, Prospective Study to Assess Immune Response to COVID-19 Vaccine in Frail Patients (VAX4FRAIL).
Lead sponsor
Azienda USL Reggio Emilia - IRCCS
Phase
Observational
Overall status
Completed
Start date
April 19, 2021
Completion date
December 31, 2022
Enrollment
747 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19, hematologic diseases, neurologic disorder, rheumatic diseases, solid tumor